Meningococcal serogroup C vaccination in students of a faculty of medicine: Coverage and perceptions

被引:0
作者
Vaysse, B. [1 ]
Joly, A. [2 ]
Ganry, O. [1 ]
Gignon, M. [1 ,3 ]
机构
[1] CHU Amiens Picardie, Dept Desante Publ, F-80054 Amiens, France
[2] Univ Picardie Jules Verne, Dept Med Gen, F-80000 Amiens, France
[3] Univ Sorbonne Paris Cite, Lab Educ & Prat Sante, EA 3412, F-93017 Bobigny, France
关键词
Vaccination; Medical students; Meningococcal meningitis; NEISSERIA-MENINGITIDIS; RISK-FACTORS; DISEASE; CARRIAGE; ASSOCIATION; POPULATION;
D O I
10.1016/j.admp.2014.10.008
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Our region is facing a situation of hyperendemic meningococcal disease (MD) with the implementation of a targeted vaccination campaign against serogroup B in 2009. Students are a population at risk. Knowing the perception of medical students on vaccination will improve education and information. Objectives. The objectives of the study were to assess immunization coverage of medical students against meningococcal serogroup C with a focus on those from hyperendemic districts, to explore their representation of the meningitis vaccine, and seek promoting factors and barriers to vaccination. Methods. A descriptive survey was conducted from self-administered questionnaires available to all students of a French medical school. A logistic regression analysis was performed to identify factors influencing vaccination. Results. The response rate was 51.6%, or 562 usable questionnaires. The declarative rate of this vaccination is 21.8%. Factors positively influencing the immunization status are the recent discussion of vaccination status, being up to date with mandatory vaccinations and young age. Reasons for non-vaccination are the lack of proposal (29.3%), lack of information (19.3%) and lack of opportunity (12.4%). The students are mostly in favor of vaccinations (87.3%). Being native of hyperendemic MD B districts does not influence their position or their vaccination status. Among the students, 52.2% consider themselves to he at risk of MD because of their medical studies. Conclusion. Information about vaccines should be systematic for students admitted to the second year, before their clinical training. Preventive health services, occupational health care services, academic and student associations can contribute to it. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 50 条
  • [31] Fluctuations in serogroup B meningococcal vaccine antigens prior to routine MenB vaccination in France
    Falguieres, Michael
    Hong, Eva
    Denizon, Melanie
    Terrade, Aude
    Taha, Muhamed-Kheir
    Deghmane, Ala-Eddine
    COMMUNICATIONS MEDICINE, 2025, 5 (01):
  • [32] Primary meningococcal pericarditis by meningococcus serogroup C
    Gutiérrez, MR
    Almeida, JL
    Cerdeña, IL
    Ojeda, FB
    Rodríguez, AD
    Trujillo, DD
    REVISTA ESPANOLA DE CARDIOLOGIA, 2000, 53 (11): : 1541 - 1544
  • [33] Changes in Meningococcal Strains in the Era of a Serogroup C Vaccination Campaign: Trends and Evolution in Belgium during the Period 1997-2012
    Mattheus, Wesley
    Hanquet, Germaine
    Collard, Jean-Marc
    Vanhoof, Raymond
    Bertrand, Sophie
    PLOS ONE, 2015, 10 (10):
  • [34] Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
    Pagliuca, Chiara
    Scaglione, Elena
    Carraturo, Francesca
    Mantova, Giuseppe
    Marino, Maria Michela
    Pishbin, Maria Virginia
    Pagliarulo, Caterina
    Colicchio, Roberta
    Salvatore, Paola
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (153):
  • [35] Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac
    Kristiansen, Paul A.
    Ba, Absatou Ky
    Ouedraogo, Abdoul-Salam
    Sanou, Idrissa
    Ouedraogo, Rasmata
    Sangare, Lassana
    Diomande, Fabien
    Kandolo, Denis
    Saga, Inger Marie
    Misegades, Lara
    Clark, Thomas A.
    Preziosi, Marie-Pierre
    Caugant, Dominique A.
    BMC INFECTIOUS DISEASES, 2014, 14
  • [36] The Impact of Childhood Meningococcal Serogroup C Conjugate Vaccine Programs in Canada
    Bettinger, Julie A.
    Scheifele, David W.
    Le Saux, Nicole
    Halperin, Scott A.
    Vaudry, Wendy
    Tsang, Raymond
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (03) : 220 - 224
  • [37] Control of serogroup W meningococcal disease outbreaks: the promise of adolescent vaccination
    Mbaeyi, Sarah
    McNamara, Lucy A.
    LANCET CHILD & ADOLESCENT HEALTH, 2022, 6 (02) : 73 - 75
  • [38] Invasive meningococcal disease burden and prophylaxis: update on serogroup B vaccination
    Caceres, Rosario
    Guillen, Jaume
    Gonzalez-Inchausti, Carmen
    Gomez Sobrino, Mamen
    FARMACEUTICOS COMUNITARIOS, 2021, 13 (04): : 28 - 42
  • [39] Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine
    Tzanakaki, Georgina
    Hong, Eva
    Kesanopoulos, Konstatinos
    Xirogianni, Athanasia
    Bambini, Stefania
    Orlandi, Luca
    Comanducci, Maurizio
    Muzzi, Alessandro
    Taha, Muhamed-Kheir
    BMC MICROBIOLOGY, 2014, 14
  • [40] Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
    Presa, Jessica
    Burman, Cynthia
    Tort, Maria J.
    Cane, Alejandro
    Bocchini Jr, Joseph A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)